These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25187048)

  • 1. Prescription drug diversion among substance-impaired pharmacists.
    Merlo LJ; Cummings SM; Cottler LB
    Am J Addict; 2014; 23(2):123-8. PubMed ID: 25187048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovering substance-impaired pharmacists' views regarding occupational risks for addiction.
    Merlo LJ; Cummings SM; Cottler LB
    J Am Pharm Assoc (2003); 2012; 52(4):480-91. PubMed ID: 22825228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
    Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
    J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment.
    Norwood CW; Wright ER
    Res Social Adm Pharm; 2016; 12(2):257-66. PubMed ID: 26143489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical prescriptions falsified by the patients: a 12-year national monitoring to assess prescription drug diversion.
    Jouanjus E; Guernec G; Lapeyre-Mestre M;
    Fundam Clin Pharmacol; 2018 Jun; 32(3):306-322. PubMed ID: 29436015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting the diverted use of psychoactive drugs by adolescents and young adults: A pilot study.
    Jouanjus E; Falcou A; Deheul S; Roussin A; Lapeyre-Mestre M
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1286-1292. PubMed ID: 30255533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.
    Inciardi JA; Surratt HL; Kurtz SP; Cicero TJ
    Pain Med; 2007 Mar; 8(2):171-83. PubMed ID: 17305688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017.
    Kurtz SP; Buttram ME; Margolin ZR; Wogenstahl K
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):700-706. PubMed ID: 30909323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coping and emotion regulation profiles as predictors of nonmedical prescription drug and illicit drug use among high-risk young adults.
    Wong CF; Silva K; Kecojevic A; Schrager SM; Bloom JJ; Iverson E; Lankenau SE
    Drug Alcohol Depend; 2013 Sep; 132(1-2):165-71. PubMed ID: 23453258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-medical use of prescription drugs, polysubstance use, and mental health in transgender adults.
    Benotsch EG; Zimmerman R; Cathers L; McNulty S; Pierce J; Heck T; Perrin PB; Snipes D
    Drug Alcohol Depend; 2013 Sep; 132(1-2):391-4. PubMed ID: 23510637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing community pharmacist engagement in a policing partnership strategy to reduce the illicit diversion of pseudoephedrine products.
    Webster JL
    Res Social Adm Pharm; 2013; 9(6):903-17. PubMed ID: 23548589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' Perspectives on Practice, Availability, and Barriers Related to Opioids in Georgia.
    Lal A; Bai J; Basri D; Yeager KA
    Am J Hosp Palliat Care; 2019 Jun; 36(6):472-477. PubMed ID: 30522338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prescription drug monitoring programs in the United States of America].
    El Burai Félix S; Mack K
    Rev Panam Salud Publica; 2014 Oct; 36(4):270-6. PubMed ID: 25563153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversion of methadone and buprenorphine from opioid substitution treatment: the importance of patients' attitudes and norms.
    Johnson B; Richert T
    J Subst Abuse Treat; 2015 Jul; 54():50-5. PubMed ID: 25744650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for prescription drug diversion among people living with HIV: a systematic scoping review.
    Chibi B; Torres NF; Sokhela ZP; Mashamba-Thompson TP
    Int J Evid Based Healthc; 2020 Mar; 18(1):5-23. PubMed ID: 31162270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients.
    Launonen E; Alho H; Kotovirta E; Wallace I; Simojoki K
    Int J Drug Policy; 2015 Sep; 26(9):875-82. PubMed ID: 25934054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug diversion administrative revocation and application hearings for medical and pharmacy practitioners: a primer for navigating murky, drug-infested waters.
    Mulrooney JJ; Hull AJ
    Albany Law Rev; 2014-2015; 78(2):101-64. PubMed ID: 25330551
    [No Abstract]   [Full Text] [Related]  

  • 18. The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis.
    Hulme S; Bright D; Nielsen S
    Drug Alcohol Depend; 2018 May; 186():242-256. PubMed ID: 29626777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does use of a prescription monitoring program change pharmacy practice?
    Green TC; Mann MR; Bowman SE; Zaller N; Soto X; Gadea J; Cordy C; Kelly P; Friedmann PD
    J Am Pharm Assoc (2003); 2013; 53(3):273-81. PubMed ID: 23699676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration-2017.
    Schneider PJ; Pedersen CA; Scheckelhoff DJ
    Am J Health Syst Pharm; 2018 Aug; 75(16):1203-1226. PubMed ID: 29903709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.